Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts

Differential Roles of Fibrinogen and von Willebrand Factor on Clot Formation and Platelet Adhesion in Reconstituted and Immune Thrombocytopenia

(2011) Mudi Misgav et al.   ANESTHESIA AND ANALGESIA

Diagnostic Performance and Therapeutic Consequence of Thromboelastometry Activated by Kaolin versus a Panel of Specific Reagents

(2011) Ole Halfdan Larsen et al.   ANESTHESIOLOGY

Long-term clinical outcomes of patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study

(2011) M. Norgaard et al.   BLOOD

Recombinant Factor VIIa: An Assessment of Evidence Regarding Its Efficacy and Safety in the Off-Label Setting

(2011) A. C. Logan et al.   Hematology-American Society of Hematology Education Program

Recombinant factor VIIa and fibrinogen display additive effect duringin vitrohaemodilution with crystalloids

(2009) C. FENGER-ERIKSEN et al.   ACTA ANAESTHESIOLOGICA SCANDINAVICA

Improved Clot Formation by Combined Administration of Activated Factor VII (NovoSeven®) and Fibrinogen (Haemocomplettan® P)

(2009) Kenichi A. Tanaka et al.   ANESTHESIA AND ANALGESIA

The Effects of Fibrinogen Levels on Thromboelastometric Variables in the Presence of Thrombocytopenia

(2009) Thomas Lang et al.   ANESTHESIA AND ANALGESIA

International consensus report on the investigation and management of primary immune thrombocytopenia

(2009) D. Provan et al.   BLOOD

Fibrinogen concentrate – a potential universal hemostatic agent

(2009) Christian Fenger-Eriksen et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

rFVIIa and a new enhanced rFVIIa-analogue, NN1731, reduce bleeding in clopidogrel-treated and in thrombocytopenic rats

(2009) B. LAURITZEN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The combination of recombinant factor VIIa and fibrinogen correct clotting ex vivo in patient samples obtained following cardiopulmonary bypass surgery

(2009) Benny Sørensen et al.   THROMBOSIS RESEARCH

The German Haemovigilance System-reports of serious adverse transfusion reactions between 1997 and 2007

(2009) B. Keller-Stanislawski et al.   TRANSFUSION MEDICINE

Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature

(2008) A. Salama et al.   ANNALS OF HEMATOLOGY

Whole blood coagulation in children with thrombocytopenia and the response to platelet replacement, recombinant factor VIIa, and a potent factor VIIa analogue

(2008) Ole H. Larsen et al.   BRITISH JOURNAL OF HAEMATOLOGY

Monitoring Recombinant Factor VIIa Treatment: Efficacy Depends on High Levels of Fibrinogen in a Model of Severe Dilutional Coagulopathy

(2008) Michael T. Ganter et al.   JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA

Treatment of immune-mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: A retrospective review of 40 patients

(2007) Joseph E. Spahr et al.   AMERICAN JOURNAL OF HEMATOLOGY